Centro de Investigación Príncipe Felipe -ko ikertzaileekin lankidetzan egindako argitalpenak (118)

2024

  1. A renal clearable fluorogenic probe for in vivo β-galactosidase activity detection during aging and senolysis

    Nature Communications, Vol. 15, Núm. 1

  2. SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells

    Cellular and Molecular Biology Letters, Vol. 29, Núm. 1

  3. The impact of sex on gene expression in the brain of schizophrenic patients: a systematic review and meta-analysis of transcriptomic studies

    Biology of Sex Differences, Vol. 15, Núm. 1

  4. The role of microRNAs in understanding sex-based differences in Alzheimer’s disease

    Biology of Sex Differences, Vol. 15, Núm. 1

2023

  1. Neuroprotective properties of queen bee acid by autophagy induction

    Cell Biology and Toxicology, Vol. 39, Núm. 3, pp. 751-770

2022

  1. Beyond the Brain: MIDS Extends BIDS to Multiple Modalities and Anatomical Regions

    Studies in health technology and informatics, Vol. 295, pp. 116-117

  2. Beyond the Brain: MIDS Extends BIDS to Multiple Modalities and Anatomical Regions

    Studies in Health Technology and Informatics

  3. Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency

    Cells, Vol. 11, Núm. 3

2021

  1. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment

    Neurotherapeutics, Vol. 18, Núm. 4, pp. 2565-2578

  2. Bioengineered in vitro 3D model of myotonic dystrophy type 1 human skeletal muscle

    Biofabrication, Vol. 13, Núm. 3

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model

    FASEB Journal, Vol. 35, Núm. 10

  5. Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 652-667

  6. Myotonic dystrophy type 1 drug development: A pipeline toward the market

    Drug Discovery Today, Vol. 26, Núm. 7, pp. 1765-1772

  7. Nrg1 haploinsufficiency alters inhibitory cortical circuits

    Neurobiology of Disease, Vol. 157

  8. Rabphilin silencing causes dilated cardiomyopathy in a Drosophila model of nephrocyte damage

    Scientific Reports, Vol. 11, Núm. 1

  9. The hallmarks of myotonic dystrophy type 1 muscle dysfunction

    Biological Reviews, Vol. 96, Núm. 2, pp. 716-730

2020

  1. Cofilin dysregulation alters actin turnover in frataxin-deficient neurons

    Scientific Reports, Vol. 10, Núm. 1

  2. Drosophila SMN2 minigene reporter model identifies moxifloxacin as a candidate therapy for SMA

    FASEB Journal, Vol. 34, Núm. 2, pp. 3021-3036

  3. Erratum: Structures of collagen IV globular domains: Insight into associated pathologies, folding and network assembly (IUCrJ (2018) 5 765-779) DOI: 10.1107/S2052252518012459)

    IUCrJ